Amundi’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,888
Closed -$147K 2087
2023
Q1
$147K Sell
2,888
-109
-4% -$5.29K ﹤0.01% 1654
2022
Q4
$138K Buy
2,997
+1,846
+160% +$86.4K ﹤0.01% 1565
2022
Q3
$58K Buy
1,151
+59
+5% +$2.95K ﹤0.01% 1643
2022
Q2
$50K Hold
1,092
﹤0.01% 1540
2022
Q1
$51K Sell
1,092
-81,217
-99% -$3.63M ﹤0.01% 1534
2021
Q4
$4.13M Sell
82,309
-38,784
-32% -$2.01M ﹤0.01% 1041
2021
Q3
$6.44M Sell
121,093
-109,251
-47% -$6.15M ﹤0.01% 954
2021
Q2
$14.1M Buy
+230,344
New +$12.2M 0.01% 756

Other funds holding LMAT

Amundi's LMAT Position: Q2 2023 in Review

Amundi sold out of LeMaitre Vascular (LMAT) in Q2 2023, closing a stake of 2,888 shares — an estimated $147K sold.

Amundi first reported a position in LMAT in Q2 2021 and held it in 8 quarters. The position peaked at $14.1M in Q2 2021. 212 funds tracked by Wall St. Rank hold LMAT as of Q2 2023.

  • Amundi reported no remaining LeMaitre Vascular position as of Q2 2023 after selling out during the quarter.
  • Amundi sold 2,888 LeMaitre Vascular shares in Q2 2023, an estimated $147K.
  • Amundi first reported a position in LeMaitre Vascular in Q2 2021 and held it in 8 quarters.
  • Amundi's LeMaitre Vascular position peaked at $14.1M in Q2 2021.
  • 212 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2023.

Based on Amundi's 13F filing for Q2 2023, filed 14 Aug 2023.